Published in Curr Allergy Asthma Rep on March 01, 2015
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet (2015) 1.11
Characterization and redox mechanism of asthma in the elderly. Oncotarget (2016) 0.81
Benralizumab: a unique IL-5 inhibitor for severe asthma. J Asthma Allergy (2016) 0.78
Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. Int J Chron Obstruct Pulmon Dis (2016) 0.77
Eosinophils in COPD: why should I care? J Bras Pneumol (2016) 0.75
Analysis of mitochondrial DNA alteration in new phenotype ACOS. BMC Pulm Med (2016) 0.75
Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Glucocorticoids and antibiotics, how do they get together? EMBO Mol Med (2015) 0.75
Current situation of asthma-COPD overlap syndrome (ACOS) in Chinese patients older than 40 years with airflow limitation: rationale and design for a multicenter, cross-sectional trial (study protocol). J Thorac Dis (2016) 0.75
Lebrikizumab treatment in adults with asthma. N Engl J Med (2011) 8.07
Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity (2007) 5.36
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10
Risk indexes for exacerbations and hospitalizations due to COPD. Chest (2007) 3.55
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med (2010) 2.80
Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest (2008) 2.37
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Airway mucus: From production to secretion. Am J Respir Cell Mol Biol (2006) 1.73
Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD (2011) 1.66
Racial differences in quality of life in patients with COPD. Chest (2011) 1.64
Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics (2006) 1.61
Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease. COPD (2008) 1.59
Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A (2009) 1.53
Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol (2013) 1.45
Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics. COPD (2008) 1.38
The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med (2011) 1.36
Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc (2008) 1.26
The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2009) 1.16
Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol (2006) 1.16
Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008. J Allergy Clin Immunol (2012) 1.16
Comparative effectiveness of noninvasive ventilation vs invasive mechanical ventilation in chronic obstructive pulmonary disease patients with acute respiratory failure. J Hosp Med (2013) 1.15
Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest (2014) 1.15
Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma (2002) 1.12
Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma. Ann Allergy Asthma Immunol (2011) 1.08
HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr (2013) 1.07
Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis (2010) 1.07
Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol (2006) 1.06
Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.04
Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD (2011) 1.02
Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res (2011) 1.02
Prevalence of airway obstruction assessed by lung function questionnaire. Mayo Clin Proc (2011) 1.01
Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis (2010) 1.01
Periostin, a novel biomarker of TH2-driven asthma. Curr Opin Pulm Med (2014) 1.00
Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest (2014) 1.00
Beta-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med (2002) 0.99
Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease. Respir Med (2011) 0.99
Targeting IgE in asthma. Curr Opin Pulm Med (2012) 0.99
Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res (2011) 0.96
Physiologic basis for improved pulmonary function after lung volume reduction. Proc Am Thorac Soc (2008) 0.96
COPD in the elderly patient. Semin Respir Crit Care Med (2010) 0.95
The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.95
Racial differences in CT phenotypes in COPD. COPD (2013) 0.95
Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma. J Biol Chem (2014) 0.94
Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. Clin Ther (2007) 0.93
Budesonide/formoterol combination in COPD: a US perspective. Int J Chron Obstruct Pulmon Dis (2010) 0.92
Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 0.91
Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease. Curr Opin Pulm Med (2005) 0.90
Asthma in older adults. Clin Chest Med (2007) 0.90
Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study. Pulm Pharmacol Ther (2008) 0.90
Ten years of tiotropium: clinical impact and patient perspectives. Int J Chron Obstruct Pulmon Dis (2013) 0.89
Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease. Proc Am Thorac Soc (2006) 0.89
The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.88
Update on the pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med (2007) 0.88
Cognitive-behavioral therapy for chronic cardiopulmonary conditions: preliminary outcomes from an open trial. Prim Care Companion J Clin Psychiatry (2010) 0.88
Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease. Metabolism (2011) 0.87
G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer. J Thorac Oncol (2012) 0.86
Age-related differences in asthma outcomes in the United States, 1988-2006. Ann Allergy Asthma Immunol (2013) 0.86
beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol (2010) 0.86
Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J (2009) 0.86
Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Ann Am Thorac Soc (2015) 0.85
Measuring the impact of a live, case-based, multiformat, interactive continuing medical education program on improving clinician knowledge and competency in evidence-based COPD care. Int J Chron Obstruct Pulmon Dis (2011) 0.85
Evaluation of obstructive lung disease with vibration response imaging. J Asthma (2008) 0.85
A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. Am J Emerg Med (2006) 0.85
Positive airway pressure therapy of OSA. Semin Respir Crit Care Med (2005) 0.85
Asthma in the elderly: current knowledge and future directions. Curr Opin Pulm Med (2010) 0.85
One hundred years of chronic obstructive pulmonary disease (COPD). Respir Med (2007) 0.84
Vitamin D and asthma. Curr Opin Pulm Med (2011) 0.84
Role of T2 inflammation biomarkers in severe asthma. Curr Opin Pulm Med (2016) 0.83
Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease. J Appl Physiol (1985) (2011) 0.83
Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Adv Ther (2009) 0.82
A detailed phenotypic analysis of immune cell populations in the bronchoalveolar lavage fluid of atopic asthmatics after segmental allergen challenge. Allergy Asthma Clin Immunol (2013) 0.82
Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials. COPD (2008) 0.82
The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma. Respir Med (2006) 0.80
Acute asthma in pregnancy. Crit Care Clin (2004) 0.80
New bronchodilators. Curr Opin Pharmacol (2012) 0.80
Effect of a primary care continuing education program on clinical practice of chronic obstructive pulmonary disease: translating theory into practice. Mayo Clin Proc (2012) 0.79
Exhaled nitric oxide parameters and functional capacity in chronic obstructive pulmonary disease. J Breath Res (2011) 0.79
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study. Clin Ther (2008) 0.79
Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives. COPD (2013) 0.78
Pharmacotherapy of obstructive sleep apnea. Ther Adv Respir Dis (2008) 0.78
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Respir Med (2012) 0.78
Arformoterol tartrate in the treatment of COPD. Expert Rev Respir Med (2010) 0.77
Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther (2009) 0.77
Optimizing safety of COPD treatments: role of the nurse practitioner. J Multidiscip Healthc (2013) 0.77
Can we predict depression in COPD? COPD (2007) 0.77
Hospital management of acute exacerbations of chronic obstructive pulmonary disease. J Hosp Med (2015) 0.77
Asthma outcomes revisited. Curr Opin Pulm Med (2013) 0.76
Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes (2012) 0.76
One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD. Chest (2014) 0.76
On measurement consistency and other hobgoblins. Sleep (2004) 0.76
Antifungals in severe asthma. Curr Opin Pulm Med (2015) 0.76